Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Myeloid Leukemia, in Relapse · Acute Myeloid Leukemia Refractory

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Universitätsklinikum Ulm, Ulm, Baden-Wurttemberg, Germany
Contact: Study coordinator (Elisa Sala, MD) · elisa.sala@uniklinik-ulm.de
Klinikum der Universität München, Munich, Bavaria, Germany
Contact: Study coordinator (Marion Subklewe, Prof.) · Marion.Subklewe@med.uni-muenchen.de
Universitätsklinikum Würzburg, Würzburg, Bavaria, Germany
Contact: Study coordinator (Chatterjee Manik, MD) · Chatterjee_m@ukw.de
Universitätsklinikum Marburg, Marburg, Hesse, Germany
Contact: Study coordinator (Stephan Metzelder, Prof.) · metzelde@med.uni-marburg.de
Universitätsklinikum Dresden, Dresden, Saxony, Germany
Contact: Study coordinator (Martin Wermke, Prof.) · martin.wermke@ukdd.de
Charité Universitätsmedizin Berlin, Berlin, Germany
Contact: Study coordinator (Jörg Westermann, Prof.) · joerg.westermann@charite.de
Universitätsklinikum Köln, Cologne, Germany
Contact: Study coordinator (Lukas Frenzel, PD) · lukas.frenzel@uk-koeln.de
Medizinische Hochschule Hannover, Hanover, Germany
Contact: Study coordinator (Felizitas Thol, Prof.) · Thol.Felicitas@mh-hannover.de
Erasmus University Medical Center, Rotterdam, Gelderland, Netherlands
Contact: Study coordinator (Mojca Jongen-Lavrencic, Dr.) · m.lavrencic@erasmusmc.nl
Amsterdam University Medical Center, Amsterdam, HV, Netherlands
Contact: Study coordinator (Arjan van de Loosdrecht, Prof.) · a.vandeloosdrecht@amsterdamumc.nl
University Medical Center Groningen (UMCG), Groningen, RB Groningen, Netherlands
Contact: Study coordinator (Gerwin Huls, Prof.) · g.huls@umcg.nl

Study leads

Tapan Maniar, MD
Study Director
AvenCell Europe GmbH

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia · Recurrent Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Duarte, United States

Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

Acute Myeloid Leukemia · Acute Myeloid Leukemia, in Relapse

Abroad (travel likely)RecruitingPHASE1

Boston, United States

PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML

Acute Myeloid Leukemia · Acute Myeloid Leukemia Refractory · Acute Myeloid Leukemia, in Relapse

Abroad (travel likely)RecruitingPHASE1

Seattle, United States

XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia

Acute Myeloid Leukemia

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China